Hoxton Farms

What Hoxton Farms does

Hoxton Farms is a London-based cultivated fat biomanufacturing company founded in 2020 by Dr Max Jamilly and Ed Steele. The company grows real animal fat — starting with pork — from stem cells using a proprietary stack combining cell biology, modular bioreactors (branded Lattice), and AI-enabled process optimization. Its product, Hoxton Fat, is positioned as a premium drop-in B2B ingredient for meat companies, plant-based brands, and broader food manufacturers producing soups, sauces, sausages, deli meats, bakery, and dumplings. The platform is underpinned by in-house computer vision models (BrightQuant, LipiQuant, and a nucleus detection model) trained on more than 200,000 experiments and 2 TB of proprietary microscopy data, and protected by a patented low-capex, modular biomanufacturing platform.

The business model is B2B ingredient supply sold directly to large food manufacturers and through regional distribution partnerships, with channel partners Sumitomo Corporation (Japan and Asia-Pacific market development) and Mitsui Chemicals (biomanufacturing scale-up and strategic investment) handling geographic expansion outside the UK. Pricing is not publicly disclosed and is negotiated per volume and specification with anchor customers. The company has not yet generated commercial revenue; its first regulatory submission to commercialize cultivated pork fat was filed with the Singapore Food Agency in November 2025, and it is also a selected participant in the UK Food Standards Agency's Cell-Cultivated Products Sandbox.

Hoxton Farms operates a 14,000 square foot pilot facility in central London supported by a team of approximately 50 scientists, engineers, chefs, and operations specialists across more than 20 nationalities. It is venture-backed by Founders Fund, F-Prime Capital, GlobalBrain, Collab Fund, SystemIQ Capital, and others, and has raised a disclosed cumulative total of approximately $25.9M across Seed and Series A rounds with additional undisclosed capital from SeaX Ventures and Mitsui Chemicals. Leadership combines deep cultivated-protein regulatory experience (CSO Vítor Espírito Santo, formerly of GOOD Meat) with alternative-protein commercialization expertise (board director Nick Halla, formerly of Impossible Foods), positioning the firm for its first commercial launches in Singapore and adjacent APAC markets.

Name

Hoxton Farms

Legal name

Hoxton Farms Limited

Website

https://hoxtonfarms.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Hoxton Farms is a London-based cultivated fat biomanufacturing company founded in 2020 that grows real pork fat from stem cells and sells it as a premium B2B ingredient to food manufacturers in meat, plant-based, and processed-food categories. It combines proprietary modular bioreactors with in-house AI models for process optimization and is pursuing first commercial approval in Singapore.

Ownership category

akta.pro rank

Product category

Cultivated fat ingredient (cellular agriculture)

NAICS

Fats and Oils Refining and Blending (311225), Animal Slaughtering and Processing (3116)

SIC

Fats & Oils (2070)

akta.pro primary industry

Cultivated (Cell-Based) Protein Foods Manufacturing (AFAKAGAI)

akta.pro secondary industries

Fat & Flavor Systems for Meat Alternatives (Cultivated Fats, Flavor Precursors, Masking) (AFANAKAH), Plant-Based Beef/Pork Alternatives (Analog Red Meat) (AFANAKAM)

Keywords

• Cultivated fat
• Cell-cultivated ingredients
• Cellular agriculture
• Food ingredient biomanufacturing
• Modular bioreactors

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Infrastructure, Supply Chain, Operations, Marketing or Sales

Revenue model

1. B2B Ingredient Sales: Hoxton Farms sells cultivated pork fat (Hoxton Fat) as a premium B2B ingredient to food manufacturers and meat companies. Revenue is generated through direct sales of cultivated fat ingredients to food brands for use in their products ranging from soups and sauces to conventional meat and meat alternatives.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Hoxton Farms cultivates real pork fat (Hoxton Fat) from pork stem cells using a proprietary low-capex, modular bioreactor platform (Lattice) combined with AI-enabled process optimization. It sells the cultivated fat as a premium drop-in B2B ingredient to food manufacturers producing meat products, plant-based meat alternatives, soups, sauces, deli meats, sausages, bakery, dumplings and related applications.

Product overview

Hoxton Farms is a Series A/B biotech startup that develops cultivated animal fats using a proprietary combination of cell biology, modular bioreactors (Lattice), and AI. The company's flagship product is Hoxton Fat, a cultivated pork fat grown from stem cells that serves as a premium B2B ingredient for food manufacturers. The AI platform comprises BrightQuant (cell counting), LipiQuant (lipid droplet analysis), and a nucleus detection model, all of which have been open-sourced for the biomanufacturing community. Founded in 2020 and headquartered in London, the company operates from a 14,000 square foot pilot facility and is pursuing regulatory approvals in Singapore, UK, North America, and Asia.

Differentiator

Problem solved

Functional benefit

Brands

• Lattice: Modular, scalable bioreactor technology for stem cells
• Hoxton Fat
• BrightQuant
• LipiQuant

Products and services

• Hoxton Fat Cultivated pork fat grown from pork stem cells using a proprietary low-capex biomanufacturing platform. Marketed as a premium drop-in B2B ingredient for meat products, plant-based meat alternatives, soups, sauces, deli meats, sausages, bakery and dumplings, with customisable taste, nutrition and performance enabled by AI.
• Lattice modular bioreactor platform Proprietary modular, scalable bioreactor technology designed for stem-cell manufacturing, enabling large-scale cell culture at low capital cost. Forms the core hardware platform for producing Hoxton Fat and other cell-based products.
• BrightQuant AI model for label-free cell counting from brightfield microscopy images, predicting cell density maps to estimate cell counts without staining, achieving approximately 5e3 cells/cm2 error across cell types and densities up to 1e5 cells/cm2. Made available to the biomanufacturing community under an open-source licence.
• LipiQuant AI segmentation model using StarDist architecture to detect intracellular lipid droplets at single-cell resolution, enabling stain-free monitoring of adipogenic differentiation over time and per-cell lipid metrics.
• Nucleus Detection Model Segmentation model for nucleus-stained images that assigns each lipid droplet to its nearest nucleus, enabling per-cell lipid metrics and supporting ground-truth labelling for BrightQuant and LipiQuant workflows.

Quantifiable outcome

• Customizable fat composition for specific nutritional profiles
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Mitsui ChemicalscoreStrategic or Co-development Partner · 19 June 2025Strategic collaboration to drive next-generation biomanufacturing in Japan, Asia, and beyond. Partnership focuses on integrating Mitsui Chemicals' advanced materials into Hoxton Farms' proprietary modular bioreactor technology. Companies will explore joint opportunities to scale production of cultivated fat across food, cosmetics, pharmaceuticals, and sustainable materials sectors. Mitsui Chemicals has made a strategic investment in Hoxton Farms as part of this collaboration.
• Sumitomo CorporationcoreStrategic or Co-development Partner · 27 March 2025Strategic collaboration to bring Hoxton Fat to market as a healthy and delicious food ingredient in Japan and Asia-Pacific. Partnership aims to foster partnerships with food manufacturers to integrate Hoxton Fat into various food products. Companies will work with food safety regulators to obtain approval before commercialisation. Will consult with Japan Association for Cellular Agriculture (JACA) for regulatory and social acceptance in Japan.
• Japan Association for Cellular Agriculture (JACA)minorOthersNon-profit think tank consulted for policy and industry guidelines for cellular agriculture adoption in Japan. Will play crucial role in shaping regulatory and social acceptance of cultivated fat in Japanese market.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Meatable: Meatable is a Dutch cultivated meat startup producing cultivated pork using similar stem-cell and bioprocess technology. It is the most direct competitor to Hoxton Farms, sharing the cultivated pork protein focus and B2B ingredient strategy, though Meatable emphasizes whole muscle cuts rather than isolated fat.
• Aleph Farms: Aleph Farms is an Israeli cultivated beef company using cell-based technology to grow thin cuts of beef. Comparable as a fellow cellular agriculture startup pursuing B2B ingredient supply for premium food manufacturers with similar technical complexity in cell-line and bioreactor development.
• Upside Foods: Upside Foods (formerly Memphis Meats) is a US leader in cultivated meat, having received the world's first USDA-FDA approval for cultivated chicken. It is a direct peer in cultivated cell-based protein manufacturing with shared regulatory, scale-up, and B2B go-to-market challenges.
• Mosa Meat: Mosa Meat is a Dutch cultivated beef company founded by the team behind the world's first cultivated beef burger. It is a direct peer in cultivated meat cell biomanufacturing with comparable regulatory and B2B commercialization pathways for food manufacturers.

Broad incumbents

• Perfect Day: Perfect Day uses precision fermentation to produce animal-identical dairy proteins (whey and casein). It is comparable as a broader alt-protein incumbent pursuing B2B ingredient sales to food manufacturers using cell-based/fermentation biomanufacturing, validating the cultivated/fermented fat and protein ingredient category.
• Impossible Foods: Impossible Foods is a major plant-based meat company whose heme (soy leghemoglobin) and fat analog technologies are designed to replicate the role of animal fat in meat products. Highly comparable as a B2B/consumer alt-protein incumbent targeting the same downstream meat-application use cases that Hoxton Farms' cultivated fat serves.

Emerging players

• Wildtype: Wildtype is a US cultivated seafood company producing cultivated salmon from fish stem cells. Comparable as an emerging player in cellular agriculture with similar cell-culture, bioreactor, and regulatory challenges, applying cultivated-cell technology to a specific animal-protein vertical.
• BlueNalu: BlueNalu is a US cultivated seafood company focused on premium fish and shellfish products. It shares the cellular agriculture production model and B2B premium ingredient positioning with Hoxton Farms, though operating in a different species vertical (seafood vs pork).

Others

• Ginkgo Bioworks: Ginkgo Bioworks is a US cell programming and biomanufacturing platform serving customers in food, cosmetics, and industrial biotech. Relevant as an enabling technology/ecosystem participant whose cell engineering and fermentation infrastructure overlaps with the upstream cell-line development challenges Hoxton Farms faces.
• Cytiva: Cytiva (Danaher) is a global provider of bioreactors, cell culture media, and bioprocessing equipment used heavily in pharmaceutical and cellular agriculture manufacturing. Comparable as an infrastructure/equipment vendor relevant to Hoxton's Lattice bioreactor platform and overall biomanufacturing scale-up strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/hoxtonfarms
• LinkedInlinkedin.com/company/hoxtonfarms
• TikToktiktok.com/@hoxtonfarms
• Facebookfacebook.com/profile.php

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds4 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hoxton Farms